The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Endogenous Nitric Oxide Synthase Inhibitor: A Novel Marker of Atherosclerosis
Open accessAbstract
Background —Exposure to risk factors such as hypertension or hypercholesterolemia decreases the bioavailability of endothelium-derived nitric oxide (NO) and impairs endothelium-dependent vasodilation. Recently, a circulating endogenous NO synthase inhibitor, asymmetric dimethylarginine (ADMA), has been detected in human plasma. The purpose of this study was to examine the relationship between plasma ADMA and atherosclerosis in humans. Methods and Results —Subjects (n=116; age, 52±1 years; male:female ratio, 100:16) underwent a complete history and physical examination, determination of serum chemistries and ADMA levels, and duplex scanning of the carotid arteries. These individuals had no symptoms of coronary or peripheral artery disease and were taking no medications. Univariate and multivariate analyses revealed that plasma levels of ADMA were positively correlated with age ( P <0.0001), mean arterial pressure ( P <0.0001), and Σ glucose (an index of glucose tolerance) ( P =0.0006). Most intriguingly, stepwise regression analysis revealed that plasma ADMA levels were significantly correlated to the intima-media thickness of the carotid artery (as measured by high-resolution ultrasonography). Conclusions —This study reveals that plasma ADMA levels are positively correlated with risk factors for atherosclerosis. Furthermore, plasma ADMA level is significantly correlated with carotid intima-media thickness. Our results suggest that this endogenous antagonist of NO synthase may be a marker of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
Menopause and Risk of Cardiovascular Disease: The Framingham Study
KANNEL, W. B., HJORTLAND, M. C., McNAMARA, P. M., & GORDON, T. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-4-447 · Cited by 1,395
Celermajer, D. S., Sorensen, K. E., Bull, C., Robinson, J., & Deanfield, J. E. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90141-4 · Cited by 1,229
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Self-citationCoronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.
Vita, J. A., Treasure, C. B., Nabel, E. G., McLenachan, J. M., Fish, R. D., Yeung, A. C., Vekshtein, V. I., Selwyn, A. P., & Ganz, P. (1990) · Circulation · doi:10.1161/01.cir.81.2.491 · Cited by 1,173
Cellular and molecular mechanisms of endothelial cell dysfunction.
Harrison, D. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119751 · Cited by 1,053
Epidemiology of coronary heart disease: The Framingham study
Castelli, W. P. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90952-5 · Cited by 1,046
L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.
Creager, M. A., Gallagher, S. J., Girerd, X. J., Coleman, S. M., Dzau, V. J., & Cooke, J. P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115987 · Cited by 813
Self-citationNITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease
Cooke, M., & Dzau, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.489 · Cited by 710
Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.
Cooke, J. P., Singer, A. H., Tsao, P., Zera, P., Rowan, R. A., & Billingham, M. E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115937 · Cited by 687
Self-citationEndothelial Dysfunction: Does It Matter? Is It Reversible?
Celermajer, D. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00189-7 · Cited by 681
Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
Levine, G. N., Keaney, J. F., & Vita, J. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320807 · Cited by 672
Craven, T. E., Ryu, J. E., Espeland, M. A., Kahl, F. R., McKinney, W. M., Toole, J. F., McMahan, M. R., Thompson, C. J., Heiss, G., & Crouse, J. R. (1990) · Circulation · doi:10.1161/01.cir.82.4.1230 · Cited by 555
Cayatte, A. J., Palacino, J. J., Horten, K., & Cohen, R. A. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.753 · Cited by 493
Böger, R. H., Bode-Böger, S. M., Thiele, W., Junker, W., Alexander, K., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.95.8.2068 · Cited by 490
Quyyumi, A. A., Dakak, N., Andrews, N. P., Husain, S., Arora, S., Gilligan, D. M., Panza, J. A., & Cannon, R. O. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117852 · Cited by 444
Kakimoto, Y., & Akazawa, S. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62716-4 · Cited by 407
Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase
MacAllister, R. J., Parry, H., Kimoto, M., Ogawa, T., Russell, R. J., Hodson, H., Whitley, G. S. J., & Vallance, P. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16069.x · Cited by 393
Ogawa, T., Kimoto, M., & Sasaoka, K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81786-0 · Cited by 360
Systemic nature of endothelial dysfunction in atherosclerosis
Anderson, T. J., Gerhard, M. D., Meredith, I. T., Charbonneau, F., Delagrange, D., Creager, M. A., Selwyn, A. P., & Ganz, P. (1995) · The American Journal of Cardiology · doi:10.1016/0002-9149(95)80017-m · Cited by 360
Egashira, K., Inou, T., Hirooka, Y., Yamada, A., Maruoka, Y., Kai, H., Sugimachi, M., Suzuki, S., & Takeshita, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116183 · Cited by 357
Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry.
Ross, R. (1993) · PubMed · Cited by 345
Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta.
Cooke, J. P., Andon, N. A., Girerd, X. J., Hirsch, A. T., & Creager, M. A. (1991) · Circulation · doi:10.1161/01.cir.83.3.1057 · Cited by 332
Self-citationEnhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine.
Tsao, P. S., McEvoy, L. M., Drexler, H., Butcher, E. C., & Cooke, J. P. (1994) · Circulation · doi:10.1161/01.cir.89.5.2176 · Cited by 324
Self-citationBode-Böger, S. M., Böger, R. H., Kienke, S., Junker, W., & Frölich, J. C. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0279 · Cited by 304
Fluid Flow Inhibits Endothelial Adhesiveness: Nitric Oxide and Transcriptional Regulation of VCAM-1
Tsao, P. S., Buitrago, R., Chan, J. R., & Cooke, J. P. (1996) · Circulation · doi:10.1161/01.cir.94.7.1682 · Cited by 300
Self-citationEndothelial dysfunction: Clinical implications
DREXLER, H. (1997) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(97)80030-8 · Cited by 293
The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease
Cohen, R. A. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(05)80002-7 · Cited by 286
Naruse, K., Shimizu, K., Muramatsu, M., Toki, Y., Miyazaki, Y., Okumura, K., Hashimoto, H., & Ito, T. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.746 · Cited by 256
Endothelial dysfunction and atherosclerosis
VANHOUTTE, P. (1997) · European Heart Journal · doi:10.1016/s0195-668x(97)90005-1 · Cited by 254
Platelet-Endothelium Interactions
Flier, J. S., Underhill, L. H., Ware, J. A., & Heistad, D. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303043280907 · Cited by 250
N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor.
Stamler, J., Mendelsohn, M. E., Amarante, P., Smick, D., Andon, N., Davies, P. F., Cooke, J. P., & Loscalzo, J. (1989) · Circulation Research · doi:10.1161/01.res.65.3.789 · Cited by 244
Self-citationBöger, R. H., Bode-Böger, S. M., Brandes, R. P., Phivthong-ngam, L., Böhme, M., Nafe, R., Mügge, A., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.96.4.1282 · Cited by 242
Matsuoka, H., Itoh, S., Kimoto, M., Kohno, K., Tamai, O., Wada, Y., Yasukawa, H., Iwami, G., Okuda, S., & Imaizumi, T. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.242 · Cited by 229
Self-citationNitric Oxide Regulates Monocyte Chemotactic Protein-1
Tsao, P. S., Wang, B.-Y., Buitrago, R., Shyy, J. Y.-J., & Cooke, J. P. (1997) · Circulation · doi:10.1161/01.cir.96.3.934 · Cited by 219
Self-citationIs NO an endogenous antiatherogenic molecule?
Cooke, J. P., & Tsao, P. S. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.653 · Cited by 216
Self-citationConcentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure
MacAllister, R. J., Rambausek, M. H., Vallance, P., Williams, D., Hoffmann, K.-H., & Ritz, E. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.12.2449 · Cited by 204
McDermott, J. R. (1976) · Biochemical Journal · doi:10.1042/bj1540179 · Cited by 192
Adams, M. R., McCredie, R., Jessup, W., Robinson, J., Sullivan, D., & Celermajer, D. S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06044-3 · Cited by 181
Regression or Progression: Dependency on Vascular Nitric Oxide
Candipan, R. C., Wang, B.-Y., Buitrago, R., Tsao, P. S., & Cooke, J. P. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.1.44 · Cited by 180
Self-citationAging-Associated Endothelial Dysfunction in Humans Is Reversed by L-Arginine
Chauhan, A., More, R. S., Mullins, P. A., Taylor, G., Petch, M. C., & Schofield, P. M. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00394-4 · Cited by 176
Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery.
Weidinger, F. F., McLenachan, J. M., Cybulsky, M. I., Gordon, J. B., Rennke, H. G., Hollenberg, N. K., Fallon, J. T., Ganz, P., & Cooke, J. P. (1990) · Circulation · doi:10.1161/01.cir.81.5.1667 · Cited by 175
Self-citationFickling, S. A., Williams, D., Vallance, P., Nussey, S. S., & Whitley, G. S. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)92335-q · Cited by 172
Dietary l-Arginine Supplementation Normalizes Platelet Aggregation in Hypercholesterolemic Humans
Wolf, A., Zalpour, C., Theilmeier, G., Wang, B.-Y., Ma, A., Anderson, B., Tsao, P. S., & Cooke, J. P. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00523-8 · Cited by 171
Self-citationAnderstam, B., Katzarski, K., & Bergström, J. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v891437 · Cited by 168
Adams, M. R., Jessup, W., & Celermajer, D. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00537-2 · Cited by 161
Metabolism of NG,NG- and NG,NG-dimethylarginine in rats
Ogawa, T., Kimoto, M., Watanabe, H., & Sasaoka, K. (1987) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(87)90060-9 · Cited by 138
Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases.
Cooke, J. P., & Dzau, V. J. (1997) · PubMed · Cited by 136
Self-citationIs NO an endogenous antiatherogenic molecule
PCooke, J., & STsao, P. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · Cited by 134
Bogle, R., MacAllister, R. J., Whitley, G. S. J., & Vallance, P. J. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.269.3.c750 · Cited by 133
Drexler, H., Fischell, T. A., Pinto, F. J., Chenzbraun, A., Botas, J., Cooke, J. P., & Alderman, E. L. (1994) · Circulation · doi:10.1161/01.cir.89.4.1615 · Cited by 128
Self-citationL-arginine attenuates platelet reactivity in hypercholesterolemic rabbits.
Tsao, P. S., Theilmeier, G., Singer, A. H., Leung, L. L. K., & Cooke, J. P. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1529 · Cited by 125
Self-citationAzuma, H., Sato, J., Hamasaki, H., Sugimoto, A., Isotani, E., & Obayashi, S. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15910.x · Cited by 123
Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit
Wang, B., Singer, A. H., Tsao, P. S., Drexler, H., Kosek, J. C., & Cooke, J. P. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90433-2 · Cited by 122
Self-citationSchwarzacher, S. P., Lim, T. T., Wang, B., Kernoff, R. S., Niebauer, J., Cooke, J. P., & Yeung, A. C. (1997) · Circulation · doi:10.1161/01.cir.95.7.1863 · Cited by 113
Self-citationCalver, A., Collier, J., Leone, A., Moncada, S., & Vallance, P. J. (1993) · PubMed · Cited by 110
Determination of dimethylated arginines in human plasma by high-performance liquid chromatography
Pettersson, A., Uggla, L., & Backman, V. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(96)00525-7 · Cited by 109
HYPERTENSION, BLOOD LIPIDS, AND CIGARETTE SMOKING AS CO‐RISK FACTORS FOR CORONARY HEART DISEASE
Kannel, W. B. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb25585.x · Cited by 78
Johnsrude, C. L., Perry, J. C., Cecchin, F., Smith, E. O., Fraley, K., Friedman, R. A., & Towbin, J. A. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80531-1 · Cited by 72
Wang, B., Candipan, R. C., Arjomandi, M., Hsiun, P. T. C., Tsao, P. S., & Cooke, J. P. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00337-3 · Cited by 71
Self-citationTheilmeier, G., Chan, J. R., Zalpour, C., Anderson, B. E., Wang, B., Wolf, A., Tsao, P. S., & Cooke, J. P. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3557 · Cited by 69
Self-citation
Cited by
Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness
Zieman, S. J., Melenovsky, V., & Kass, D. A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160548.78317.29 · Cited by 1,854
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Nitric Oxide as a Signaling Molecule in the Vascular System: An Overview
Ignarro, L. J., Cirino, G., Casini, A., & Napoli, C. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199912000-00016 · Cited by 763
Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine
Stühlinger, M. C., Tsao, P. S., Her, J.-H., Kimoto, M., Balint, R. F., & Cooke, J. P. (2001) · Circulation · doi:10.1161/hc4601.098514 · Cited by 662
Self-citationLin, K. Y., Ito, A., Asagami, T., Tsao, P. S., Adimoolam, S., Kimoto, M., Tsuji, H., Reaven, G. M., & Cooke, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000027109.14149.67 · Cited by 651
Self-citation
Metadata
- Authors
- Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T.
- Venue
- Circulation
- Published
- 1999-03-09
- Volume
- 99
- Issue
- 9
- Pages
- 1141-1146
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2000881220
- Cited by
- 756
- References
- 63
- FWCI
- 19.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.